Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000842300 | SCV000984308 | likely benign | not provided | 2018-04-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000842300 | SCV001143197 | likely benign | not provided | 2018-09-30 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000842300 | SCV001471937 | likely benign | not provided | 2020-06-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002235140 | SCV001608828 | likely benign | Osteogenesis imperfecta type I; Ehlers-Danlos syndrome, classic type, 1 | 2023-04-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390728 | SCV002705322 | likely benign | Cardiovascular phenotype | 2022-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000842300 | SCV004185464 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | COL1A2: BP4, BP7 |